MMManish K. Madasu

Manish K. Madasu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Manish K. Madasu has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Peripheral kappa opioid receptors modulate cold hypersensitivity in a mouse model of chemotherapy-induced neuropathy

    by Manish K. Madasu, Loc V. Thang, Christian C. Ohazurume, Sriya Chebrolu, Richard A. Houghten, Sravanthi Bandla, Tayler D. Sheahan, Audra M. Foshage, Jay P. McLaughlin, Jordan G. McCall, et al.

    Noxious cold sensation is commonly associated with peripheral neuropathies; however, there has been limited progress in understanding the mechanism. Here, we identify a novel role for peripherally expressed kappa opioid receptors [KORs] in noxious cold hypersensitivity in a mouse model of chemotherapy. In this model, we show that oxaliplatin-induced cold hypersensitivity is attenuated using norbinaltorphimine (NorBNI, KOR antagonist (10 mg/kg, i.p.) in both male and female mice. To further examine the role of KORs in cold hypersensitivity, we show that activation of KOR with U50,488 (KOR agonist, 5 mg/kg i.p.) significantly increases the number of jumps on a cold plate at 3°C as compared to controls, which is attenuated by KOR antagonist NorBNI. We have determined that this effect is mediated through peripheral KORs using both pharmacology and a peripherally restricted KOR agonist, ff(nle)r-NH2. Using a conditional knockout mouse model of KOR in the dorsal root ganglia (using PirtCre;Oprk fl/fl ), we see reduced U50488-induced noxious cold hypersensitivity as compared to controls in male and female mice, confirming the role of KORs in the dorsal root ganglia in mediating cold hypersensitivity. To confirm the role of peripheral KORs in oxaliplatin-induced cold allodynia, we use the PirtCre;Oprk fl/fl in our oxaliplatin-induced cold allodynia model. Here, we show that in the absence of KORs in dorsal root ganglia, oxaliplatin-induced cold hypersensitivity is attenuated in male and female mice. Overall, our data suggest that peripheral KORs modulate cold hypersensitivity in a mouse model of chemotherapy.

  • Spared nerve injury decreases motivation in long-access homecage-based operant tasks in mice

    by Makenzie R. Norris, Léa J. Becker, John Bilbily, Yu-Hsuan Chang, Gustavo Borges, Samantha S. Dunn, Manish K. Madasu, Chayla R. Vazquez, Solana A. Cariello, Ream Al-Hasani, et al.

    Neuropathic pain causes both sensory and emotional maladaptation. Preclinical animal studies of neuropathic pain-induced negative affect could result in novel insights into the mechanisms of chronic pain. Modeling pain–induced negative affect, however, is variable across research groups and conditions. The same injury may or may not produce robust negative affective behavioral responses across different species, strains, and laboratories. Here, we sought to identify negative affective consequences of the spared nerve injury model on C57BL/6J male and female mice. We found no significant effect of spared nerve injury across a variety of approach-avoidance conflict, hedonic choice, and coping strategy assays. We hypothesized these inconsistencies may stem in part from the short test duration of these assays. To test this hypothesis, we used the homecage-based Feeding Experimentation Device version 3 to conduct 12-hour, overnight progressive ratio testing to determine whether mice with chronic spared nerve injury had decreased motivation to earn palatable food rewards. Our data demonstrate that despite equivalent task learning, spared nerve injury mice are less motivated to work for a sugar pellet than sham controls. Furthermore, when we normalized behavioral responses across all the behavioral assays we tested, we found that a combined normalized behavioral score is predictive of injury state and significantly correlates with mechanical thresholds. Together, these results suggest that homecage-based operant behaviors provide a useful platform for modeling nerve injury-induced negative affect and that valuable pain-related information can arise from agglomerative data analyses across behavioral assays—even when individual inferential statistics do not demonstrate significant mean differences.


  • Open Access

    Neuropathic injury drives a generalized negative affective state in mice

    by Makenzie R. Norris, John Bilbily, Léa J. Becker, Gustavo Borges, Yu-Hsuan Chang, Samantha S. Dunn, Manish K. Madasu, Ream Al-Hasani, Meaghan C. Creed, Jordan G. McCall

    Neuropathic pain causes both sensory and emotional maladaptation. Preclinical animal studies of neuropathic pain-induced negative affect could result in novel insights into the mechanisms of chronic pain. Modeling pain-induced negative affect, however, is variable across research groups and conditions. The same injury may or may not produce robust negative affective behavioral responses across different species, strains, and laboratories. Here we sought to identify negative affective consequences of the spared nerve injury model on C57BL/6J male and female mice. We found no significant effect of spared nerve injury across a variety of approach-avoidance, hedonic choice, and coping strategy assays. We hypothesized these inconsistencies may stem in part from the short test duration of these assays. To test this hypothesis, we used the homecage-based Feeding Experimentation Device version 3 to conduct 12-hour, overnight progressive ratio testing to determine whether mice with chronic spared nerve injury had decreased motivation to earn palatable food rewards. Our data demonstrate that despite equivalent task learning, spared nerve injury mice are less motivated to work for a sugar pellet than sham controls. Further, when we normalized behavioral responses across all the behavioral assays we tested, we found that a combined normalized behavioral score is predictive of injury-state and significantly correlates with mechanical thresholds. Together these results suggest that homecage-based operant behaviors provide a useful platform for modeling nerve injury-induced negative affect and that valuable pain-related information can arise from agglomerative data analyses across behavioral assays - even when individual inferential statistics do not demonstrate significant mean differences.


  • Open Access

    Perinatal Oxycodone Exposure Causes Long Term Sex-Dependent Changes in Sensory and Reward Processing in Adult Mice

    by Elena Minakova, Marwa O. Mikati, Manish K. Madasu, Sineadh M. Conway, Justin W. Baldwin, Raylynn G. Swift, Katherine B. McCullough, Joseph D. Dougherty, Susan E. Maloney, Ream Al-Hasani

    In utero opioid exposure is associated with lower weight and a Neonatal Opioid Withdrawal Syndrome (NOWS) at birth, along with longer-term adverse neurodevelopmental outcomes and mood disorders. While NOWS is sometimes treated with continued opioids, clinical studies have not addressed if long-term neurobehavioral outcomes are worsened with continued postnatal exposure to opioids. In addition, pre-clinical studies comparing in utero only opioid exposure to continued post-natal opioid administration for withdrawal mitigation are lacking. Therefore, we implemented a rodent perinatal opioid exposure model of Oxycodone (Oxy) exposure for comparison of long-term consequences of Oxy exposure until birth (Short Oxy) to the impact of continued postnatal opioid exposure (Long Oxy) spanning gestation through birth and lactation. Short Oxy exposure was associated with a sex-specific increase in weight gain trajectory in adult male mice. Long Oxy exposure caused an increased weight gain trajectory in adult males, sex-dependent changes in morphine conditioned place preference, and alterations in nociceptive processing in females. Importantly, there was no evidence of long-term social behavioral deficits, anxiety, hyperactivity, or memory deficits following Short or Long Oxy exposure. Our findings suggest that offspring with prolonged opioid exposure experienced some long-term sequelae compared to pups with opioid cessation at birth. These results highlight the potential long-term consequences of opioid administration as a mitigation strategy for clinical NOWS symptomology and suggest alternatives should be explored.

  • Peripheral kappa opioid receptor activation drives cold hypersensitivity in mice

    by Manish K. Madasu, Loc V. Thang, Priyanka Chilukuri, Sree Palanisamy, Joel S. Arackal, Tayler D. Sheahan, Jay P. McLaughlin, Richard A. Houghten, Jordan G. McCall, Ream Al-Hasani


  • Open Access

    Design of first in class bitopic ligands targeting the sodium binding pocket in opioid receptors

    by Abdelfattah Faouzi, Saheem Zaidi, Tao Che, Chad Kormos, Tiffany Zhang, Manish Madasu, Shainnel Eans, Chloe Simons, Ying-Xian Pan, Jay McLaughlin, et al.

    Opioid agonists have been used in the field of pain management for centuries, but are considered a major public health concern, especially in the US. One of the biggest challenges consists in understanding the ability to target specifically the different subtypes of opioid receptors and to trigger a specific functional response correlating with an in vivo analgesic response devoid of side‐effects. These opioid receptors are part of the GPCRs family, which is known to have common features across different subfamilies. One important feature of these receptors is the presence of allosteric binding pockets, which is progressively gaining momentum as a novel target for current therapeutic strategies. We hypothesized that targeting an allosteric site could potentially allow for receptor functional selectivity, helping to reduce the overall side effects profile. One site, in particular, known as the Na + binding pocket, is known to play a key role in GPCR function and is thought to be the center of the functional mechanism, with several bias switches characterized in the pocket residues (Katritch et al ., Trends Biochem Sci . 2014). Here we report structure‐based rational drug design of bitopic ligands targeting the Na + pocket of mu (MOR) and kappa opioid receptors (KOR). Our designed bitopics show high affinity, subtype selectivity, G‐protein bias and analgesic actions in mice. Mutations in Na + binding pocket diminished functional potency validating allosteric site targeting. Together, results suggest the possibility of achieving subtype selectivity and identification of an additional subpocket in both MOR and KOR to reduce βarrestin‐2 recruitment by targeting an allosteric pocket in the opioid receptors. The highly conserved constitution of the Na + binding pocket opens the opportunity for rational discovery of new GPCR modulators with desired functional, and potentially therapeutic profile for opioids as well as other class A GPCRs. Support or Funding Information: We gratefully acknowledge the financial support from Faculty Research Incentive Fund, NIDA, NIAAA and US department of defense. We also would like to thank the Philippe Foundation for their financial support.